Preview

Oncohematology

Advanced search
Fullscreen

For citations:


Mingalimov M.A., Baryakh E.A., Misyurin A.V., Kesaeva L.A., Mkrtchyan A.S., Misyurina E.N., Tolstykh T.N., Orlova M.S., Akhmadeeva A.A., Chudnova T.S., Ivanova D.D., Kochneva O.L., Zotina E.N., Makeshova A.B., Andreev S.S., Yatskov K.V., Samsonova I.V., Lysenko M.A. Personalized genotype-directed antitumor therapy for newly diagnosed diffuse large B-cell lymphoma: efficacy and toxicity of the R-CHOP-X protocol in a single-center, non-randomized, prospective clinical trial (first results). Oncohematology. 2024;19(4):84-92. (In Russ.) https://doi.org/10.17650/1818-8346-2024-19-4-84-92



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1818-8346 (Print)
ISSN 2413-4023 (Online)